>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance:

CCUR +11.3%, CHS +5.8%, VEEV +4.5%, TRR +3.5%, OOMA +1.9%, BOBE +1.8%, SFL +0.9%

M&A news:

ININ +5.6% (to be acquired by Genesys for $60.50/share in cash, or approximately $1.4 bln)

Select EU financial related names showing strength:

CS +3.8%, BCS +2.6%, RBS +2.1%, HSBC +2%, BBVA +1.5%, LYG +1.3%

Other news:

FELP +8.5% (Completed its out-of-court restructuring of more than $1.4 bln in indebtedness)
RXDX +7.3% (announces FDA approval of an investigational device exemption for its RNA-based companion diagnostic, next-generation sequencing assay)
GSAT +5.9% (Signed a strategic agreement with Carmanah Technologies)
AEG +4.3% (still checking)
DB +3.1% (Reports Deutsche Bank was in discussions with Commerzbank (CRZBY) over possible merger, according to Manager Magazine, but CEO dismissed report on CNBC)
ORAN +3.1% (in sympathy with peer Bouygues SA which reported better than expected earnings overnight), CLVS +2.4% (Amended its license agreement with Pfizer (PFE))
WB +2% (Weibo shareholder SINA Corp (SINA) Board authorizes the distribution of Weibo shares on a pro rata basis; SINA decreases stake in co to 51% from 54%)
PSG +1.5% (Announced that it has executed amendments with its lenders, extending the deadline for filing its annual report on Form 10-K; also disclosed that it had hired Centerview Partners to review and evaluate strategic alternatives)

Analyst comments: